Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
diagnosis
|
| gptkbp:alternativeTo |
ROMA test
|
| gptkbp:analyzes |
blood sample
|
| gptkbp:approvedBy |
gptkb:FDA
2009 |
| gptkbp:category |
multivariate index assay
|
| gptkbp:developedBy |
gptkb:Vermillion,_Inc.
|
| gptkbp:hasBiomarker |
gptkb:transthyretin
gptkb:beta-2_microglobulin gptkb:transferrin apolipoprotein A1 CA125 |
| https://www.w3.org/2000/01/rdf-schema#label |
OVA1
|
| gptkbp:marketedAs |
Aspira Women's Health
|
| gptkbp:measures |
five protein biomarkers
|
| gptkbp:purpose |
to help determine need for referral to gynecologic oncologist
|
| gptkbp:regulates |
FDA cleared
|
| gptkbp:type |
in vitro diagnostic
|
| gptkbp:usedFor |
ovarian cancer risk assessment
women with pelvic mass |
| gptkbp:bfsParent |
gptkb:Vermillion,_Inc.
|
| gptkbp:bfsLayer |
7
|